Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Increases By 2,468.9%
Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Increases By 2,468.9%
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 156,700 shares, a growth of 2,468.9% from the November 30th total of 6,100 shares. Based on an average daily trading volume, of 745,200 shares, the short-interest ratio is currently 0.2 days.
Q 生物醫學公司（OTCMKTS：QBIO-獲取評級）是在十二月份的短期利益大增長的接收者。截至十二月十五日，短期利息共達 156,700 股，較十一月三十日共 6,100 股股份增長了 2,468.9%。根據平均每日交易量 745,200 股，短息比率目前為 0.2 天。
Q BioMed Price Performance
Q 生物醫學價格表現
Shares of QBIO traded down $0.00 during mid-day trading on Wednesday, hitting $0.01. 642,508 shares of the company's stock were exchanged, compared to its average volume of 443,292. Q BioMed has a 52 week low of $0.01 and a 52 week high of $0.58. The company has a 50-day simple moving average of $0.02 and a 200 day simple moving average of $0.03.
QBIO 的股票在周三中間交易期間下跌了 0.00 美元，觸及 0.01 美元。該公司股票的 642,508 股被交換，而其平均交易量為 443,292。Q 生物醫學有 52 周低點 0.01 美元，52 周高點為 0.58 美元。該公司擁有 50 天的簡單移動平均線 0.02 美元，以及 200 天的簡單移動平均線 0.03 美元。
Q BioMed (OTCMKTS:QBIO – Get Rating) last issued its earnings results on Thursday, November 3rd. The company reported ($0.03) earnings per share for the quarter. The firm had revenue of $0.03 million during the quarter.
Q 生物醫學 (OTCMKTS: QBIO-獲取評級) 上次公佈其盈利業績日期為 11 月 3 日（星期四）。該公司報告了本季度每股盈利（0.03 美元）。該公司在本季度的收入為 0.03 萬美元。
About Q BioMed
關於 Q 生物醫學
Q BioMed Inc, a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain.
Q BioMed Inc 是一家生物醫學加速和開發公司，專注於生命科學和醫療保健公司的許可，獲取和提供資源。該公司提供氯化鍶 SR89 和 Mestron，這是一種用於治療轉移性骨癌疼痛的放射性藥物治療。
See Also
另請參閱
- Get a free copy of the StockNews.com research report on Q BioMed (QBIO)
- The Top Three Stocks Analysts Say To Buy
- Can Dick's Sporting Goods Stock Score Another Win In Q4?
- Yum! Brands Looks Tasty in 2023
- Why Did Immutep Ltd Stock Soar Recently?
- 3 Industrial Stocks to Help Build Your 2023 Watchlist
- 免費獲取有關 Q 生物醫學（QBIO）的研究報告
- 前三名股票分析師說購買
- 迪克的體育用品股票可以在第四季度獲得另一個勝利嗎？
- 百勝！品牌在 2023 年看起來很美味
- 為什麼 Immutep 有限公司股票最近飆升？
- 3 種工業股票可幫助建立您的 2023 觀察列表
Receive News & Ratings for Q BioMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q BioMed and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Q 生物醫學日報的最新消息和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Q BioMed 和相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。